We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PHAT market cap is 604.46M. The company's latest EPS is USD -2.9482 and P/E is -3.00.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 682k | 1.91M |
| Operating Income | -30.08M | -31.7M | -35.66M | -69.88M | -69.95M |
| Net Income | -37.81M | -40.97M | -43.24M | -79.57M | -82.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 682k |
| Operating Income | -106.22M | -125.67M | -135.08M | -172.44M | -167.31M |
| Net Income | -255.13M | -129.07M | -143.88M | -197.72M | -201.59M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 144.01M | 265.04M | 236.99M | 413.84M | 356.5M |
| Total Liabilities | 234.21M | 247.44M | 254.77M | 486.6M | 505M |
| Total Equity | -90.2M | 17.6M | -17.77M | -72.76M | -148.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 257.18M | 295.11M | 189.43M | 164.81M | 413.84M |
| Total Liabilities | 29.22M | 100.84M | 117.28M | 239.62M | 486.6M |
| Total Equity | 227.96M | 194.27M | 72.16M | -74.81M | -72.76M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -39.67M | -61.87M | -93.78M | -137.58M | -69.02M |
| Investing | -214k | -220k | -1.16M | -1.63M | -40k |
| Financing | 14.07M | 155.57M | 155.59M | 367.58M | 9.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -36.51M | -69.69M | -148.62M | -146.53M | -137.58M |
| Investing | -25.25M | -1.04M | -328k | -1.04M | -1.63M |
| Financing | 304.65M | 114.46M | 44.71M | 120.04M | 367.58M |
| Market Cap | 604.46M |
| Price to Earnings Ratio | -3.00 |
| Price to Sales Ratio | 884 |
| Price to Cash Ratio | 1.58 |
| Price to Book Ratio | -8.31 |
| Dividend Yield | - |
| Shares Outstanding | 68.38M |
| Average Volume (1 week) | 770.84k |
| Average Volume (1 Month) | 1.97M |
| 52 Week Change | 20.27% |
| 52 Week High | 19.675 |
| 52 Week Low | 6.065 |
| Spread (Intraday) | 0.23 (2.56%) |
| Company Name | Phathom Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.phathompharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
